Aptevo Therapeutics (APVO) Raw Materials (2015 - 2019)
Aptevo Therapeutics (APVO) posted Raw Materials of $491000.0 for Q4 2019, down 23.28% sequentially from $640000.0 in Q3 2019, and up 153.09% YoY from $194000.0 in Q4 2018.
Aptevo Therapeutics (APVO) Raw Materials (2015 - 2019) Analysis & Trends
Aptevo Therapeutics has reported Raw Materials for 5 years, with the latest figure at $491000.0 in Q4 2019.
- Quarterly Raw Materials rose 153.09% year-over-year to $491000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $491000.0 (up 153.09% YoY) and the FY2019 annual result came in at $491000.0, up 153.09% from the prior year.
- Raw Materials slipped to $491000.0 in Q4 2019 per APVO's latest filing, from $640000.0 in the prior quarter.
- Over five years, Raw Materials peaked at $7.6 million in Q2 2016 and troughed at $43000.0 in Q3 2018.
- A 5-year average of $1.4 million and a median of $244500.0 in 2017 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2017 and 2019: Raw Materials plunged 96.74% in 2017, then surged 1388.37% in 2019.
- Over 5 years, Raw Materials stood at $6.5 million in 2015, then tumbled by 96.01% to $260000.0 in 2016, then tumbled by 78.46% to $56000.0 in 2017, then soared by 246.43% to $194000.0 in 2018, then surged by 153.09% to $491000.0 in 2019.
- According to Business Quant data, Raw Materials over the past three periods registered $491000.0, $640000.0, and $612000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - |
| 10 | Aptevo Therapeutics | 3.21 Mn | -6.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 491,000.00 |
| Sep 30, 2019 | 640,000.00 |
| Jun 30, 2019 | 612,000.00 |
| Mar 31, 2019 | 162,000.00 |
| Dec 31, 2018 | 194,000.00 |
| Sep 30, 2018 | 43,000.00 |
| Jun 30, 2018 | 46,000.00 |
| Mar 31, 2018 | 51,000.00 |
| Dec 31, 2017 | 56,000.00 |
| Sep 30, 2017 | 240,000.00 |
| Jun 30, 2017 | 249,000.00 |
| Mar 31, 2017 | 224,000.00 |
| Dec 31, 2016 | 260,000.00 |
| Sep 30, 2016 | 4.64 Mn |
| Jun 30, 2016 | 7.65 Mn |
| Dec 31, 2015 | 6.52 Mn |